ResMed, Inspire Medical Slump After Lilly's Positive Zepbound Data; Citi Downgrades
ResMed Analyst Ratings
ResMed Analyst Ratings
ResMed Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Accolade (ACCD), Resmed (RMD)
RBC Adjusts Price Target on ResMed to $200 From $187
Analysts' Opinions Are Mixed on These Healthcare Stocks: Integer Holdings (ITGR), Resmed (RMD) and PTC Therapeutics (PTCT)
KeyBanc Keeps Their Buy Rating on Resmed (RMD)
Resmed Stock Poised for Growth: Buy Rating Affirmed Amid Revenue Upswing and Margin Expansion
Analysts Offer Insights on Healthcare Companies: Novartis AG (Six Swiss: CH:NOVN), Carl Zeiss Meditec (GB:0DHC) and Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (AU:RMD)
Analysts Are Bullish on Top Healthcare Stocks: InMode (INMD), Resmed (RMD)
Analyst Upgrades Resmed Price Target to $224, Maintains Buy Rating Amidst Market Opportunities and OSA Trial Developments
ResMed Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Merck & Company (MRK)
ResMed Analyst Ratings
Morgan Stanley Adjusts Resmed's Price Target to AU$31.80 From AU$28.60, Keeps at Overweight
Evans & Partners Upgrades ResMed to Positive From Neutral, Price Target Is AU$31
ResMed Analyst Ratings
Oppenheimer Keeps Their Buy Rating on Resmed (RMD)
Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Demant (OtherWILLF)